- Home
- LAZ vs PRCT Comparison
LAZ vs PRCT Comparison
Compare LAZ & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZ
- PRCT
- Stock Information
- Founded
- LAZ 1848
- PRCT 2009
- Country
- LAZ United States
- PRCT United States
- Employees
- LAZ N/A
- PRCT N/A
- Industry
- LAZ Investment Managers
- PRCT Medical Specialities
- Sector
- LAZ Finance
- PRCT Health Care
- Exchange
- LAZ Nasdaq
- PRCT Nasdaq
- Market Cap
- LAZ 5.1B
- PRCT 5.3B
- IPO Year
- LAZ 2005
- PRCT 2021
- Fundamental
- Price
- LAZ $52.04
- PRCT $81.17
- Analyst Decision
- LAZ Hold
- PRCT Strong Buy
- Analyst Count
- LAZ 7
- PRCT 7
- Target Price
- LAZ $52.29
- PRCT $97.86
- AVG Volume (30 Days)
- LAZ 880.8K
- PRCT 592.2K
- Earning Date
- LAZ 01-30-2025
- PRCT 10-28-2024
- Dividend Yield
- LAZ 3.84%
- PRCT N/A
- EPS Growth
- LAZ N/A
- PRCT N/A
- EPS
- LAZ 2.55
- PRCT N/A
- Revenue
- LAZ $3,047,514,000.00
- PRCT $199,843,000.00
- Revenue This Year
- LAZ $14.52
- PRCT $67.07
- Revenue Next Year
- LAZ $13.40
- PRCT $40.64
- P/E Ratio
- LAZ $20.38
- PRCT N/A
- Revenue Growth
- LAZ 25.34
- PRCT 71.71
- 52 Week Low
- LAZ $34.25
- PRCT $39.48
- 52 Week High
- LAZ $61.14
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LAZ 41.68
- PRCT 33.77
- Support Level
- LAZ $52.40
- PRCT $79.30
- Resistance Level
- LAZ $54.42
- PRCT $92.92
- Average True Range (ATR)
- LAZ 1.73
- PRCT 4.06
- MACD
- LAZ -0.59
- PRCT -1.87
- Stochastic Oscillator
- LAZ 31.78
- PRCT 9.21
About LAZ Lazard Inc.
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.